HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.
about
Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathwayMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldCancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectivesThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesCIViC databaseSynergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.Hypoxia triggers a Nur77-β-catenin feed-forward loop to promote the invasive growth of colon cancer cells.Biomarker correlation network in colorectal carcinoma by tumor anatomic location.MicroRNA-22 regulates hypoxia signaling in colon cancer cells.Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.A systems biology approach to the global analysis of transcription factors in colorectal cancer.Hypoxia and lineage specification of cell line-derived colorectal cancer stem cellsInhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II).Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Hainan population: a case-control studyhypoxia-inducible factors activate CD133 promoter through ETS family transcription factors.Identification of upstream regulators for prognostic expression signature genes in colorectal cancer.Prognostic value and clinicopathological differences of HIFs in colorectal cancer: evidence from meta-analysis.Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(-/-) mice.Hispidulin prevents hypoxia-induced epithelial-mesenchymal transition in human colon carcinoma cells.Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IκBThe critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activationRegulation of hypoxia-inducible factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and Krüppel-like factor 5.Molecular pathways involved in colorectal cancer: implications for disease behavior and preventionAdvances in glucose metabolism research in colorectal cancerHsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome.Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo-/- mice.Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy.Increased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal CancerHypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer.Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.Hypoxia-mediated biological control.Modulation of macrophage activation and programming in immunity.Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance.Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells.C-Glycosyl Flavonoids from Beta vulgaris Cicla and Betalains from Beta vulgaris rubra: Antioxidant, Anticancer and Antiinflammatory Activities-A Review.
P2860
Q24304210-60884B7F-EB59-488B-928A-6CE731B333A8Q24620628-1DFFCCB9-F8BF-496F-A417-8FF77683FC8BQ27024651-8C4D40E7-1A97-4B2B-9B93-ADE755B0FD4CQ27025579-07A95D5A-DCE0-4A0B-B9E7-74B54E4616FBQ27612411-14F2F436-112E-4C90-B622-997FD2326DA3Q28484315-77287CEE-0597-420D-B7FE-78C9384EF2CFQ30249160-0BE3CB80-F37D-4E48-BCFF-B2CBAC8A4645Q30408026-3E4336BF-ACC5-4BC9-8229-DB678CF1A19DQ33808553-E365F7B9-ECD1-4141-BF80-D88E47D6F404Q33918344-5F7508B6-5F43-43E8-A032-606287DB7158Q33942280-54DDC31C-BBD2-405B-BEE8-58C194C5F725Q34361370-6D89D478-D09B-40A8-B0CD-BBF21DA07B8DQ34693614-EAE986EA-0ECB-47C1-87EE-EE8394DC7675Q34778239-B217A5CE-A5A5-4C0E-8984-836514849675Q34787172-13DC5276-B976-497F-86E5-04666237712EQ34805209-6B25E52D-1C1E-4D40-A9FF-63E01A0493FEQ34978625-7D96FB3A-EB29-40CE-AA6F-BEC244254ED6Q35063723-933A2594-7988-4269-BFCB-8B5FFAF37FDEQ35084957-FBD556B0-7C02-44C6-87CF-AE0A192691FEQ35666423-3A88F08D-6748-4CAD-A92B-2E318F1D4C99Q35709343-7BC1724A-4683-42BB-97B5-91C8E9BD13BFQ36299669-5EEA78CD-8D17-4EC9-9363-5171E827611AQ36510909-9FB837F6-93A3-4CD6-89B3-7D5E7857B845Q36560911-B7F7441F-899B-4AD0-B0CF-17AEFBD9CDCFQ37132090-65FC7111-E740-4D7B-819A-7D25EBD3E075Q37139174-9F81B3EE-4004-4ACC-A0B1-BEEBD8D49162Q37204593-ECC0F03A-973B-4813-BAD3-67F35119111CQ37206009-6EF18BD2-1ECA-4AF2-979F-84F288948238Q37351778-4BE4136C-9F83-43E6-9C81-AA1E28D6AFCDQ37376690-D87EB12F-F365-485A-8E5C-051CD6C94EC0Q37520269-D67991DA-9F22-476C-ADBF-F04AEB97ADEFQ37550889-AB77B9CE-4FED-425E-A8CE-DB775B098349Q37689019-CA258012-080D-497F-836B-E44A6BE28047Q37702084-AA1F511C-01B5-4A39-AF84-16B4A8DDA771Q37723067-ECC37D43-7234-49B8-A0C2-0F26E5DFC6DBQ37843943-96269BF4-3406-454E-B3B1-133C9C59E5E6Q38025044-B8132B49-9105-43D4-920F-6B02D7127C3DQ38957845-5115A01A-3F67-4856-BD39-8C3AC52C6D89Q39092675-DF12F24A-5EB2-450B-9873-7C887772AFDAQ39278666-5231052F-B7A2-409E-BBF2-D7B51B4F1C24
P2860
HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@ast
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@en
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@nl
type
label
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@ast
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@en
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@nl
altLabel
HIF1A Overexpression Is Associ ...... hort of 731 Colorectal Cancers
@en
prefLabel
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@ast
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@en
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@nl
P2093
P2860
P50
P3181
P1476
HIF1A overexpression is associ ...... ort of 731 colorectal cancers.
@en
P2093
Andrew T Chan
Daniel C Chung
Kaori Shima
Katsuhiko Nosho
Natsumi Irahara
Shuji Ogino
Yoshifumi Baba
P2860
P304
P3181
P356
10.2353/AJPATH.2010.090972
P407
P577
2010-05-01T00:00:00Z